Anti-inflammatory Effects of 4-Phenyl-3-butenoic Acid and 5-(Acetylamino)-4-oxo-6-phenyl-2-hexenoic Acid Methyl Ester, Potential Inhibitors of Neuropeptide Bioactivation

John D. Bauer; Jeffrey A. Sunman; Michael S. Foster; Jeremy R. Thompson; Alison A. Ogonowski; Stephen J. Cutler; Sheldon W. May; Stanley H. Pollock

doi:10.1124/jpet.106.110940

OtherInflammation, Immunopharmacology, and Asthma

Anti-inflammatory Effects of 4-Phenyl-3-butenoic Acid and 5-(Acetylamino)-4-oxo-6-phenyl-2-hexenoic Acid Methyl Ester, Potential Inhibitors of Neuropeptide Bioactivation

John D. Bauer, Jeffrey A. Sunman, Michael S. Foster, Jeremy R. Thompson, Alison A. Ogonowski, Stephen J. Cutler, Sheldon W. May and Stanley H. Pollock

Journal of Pharmacology and Experimental Therapeutics November 30, 2006, DOI: https://doi.org/10.1124/jpet.106.110940

John D. Bauer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeffrey A. Sunman

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael S. Foster

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeremy R. Thompson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alison A. Ogonowski

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stephen J. Cutler

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sheldon W. May

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stanley H. Pollock

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
eLetters
PDF

This is a PDF-only article. The first page of the PDF of this article appears below.

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 365, Issue 2

1 May 2018

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Anti-inflammatory Effects of 4-Phenyl-3-butenoic Acid and 5-(Acetylamino)-4-oxo-6-phenyl-2-hexenoic Acid Methyl Ester, Potential Inhibitors of Neuropeptide Bioactivation

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

Citation Tools

OtherInflammation, Immunopharmacology, and Asthma

Anti-inflammatory Effects of 4-Phenyl-3-butenoic Acid and 5-(Acetylamino)-4-oxo-6-phenyl-2-hexenoic Acid Methyl Ester, Potential Inhibitors of Neuropeptide Bioactivation

John D. Bauer, Jeffrey A. Sunman, Michael S. Foster, Jeremy R. Thompson, Alison A. Ogonowski, Stephen J. Cutler, Sheldon W. May and Stanley H. Pollock

Journal of Pharmacology and Experimental Therapeutics November 30, 2006, DOI: https://doi.org/10.1124/jpet.106.110940

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

OtherInflammation, Immunopharmacology, and Asthma

Anti-inflammatory Effects of 4-Phenyl-3-butenoic Acid and 5-(Acetylamino)-4-oxo-6-phenyl-2-hexenoic Acid Methyl Ester, Potential Inhibitors of Neuropeptide Bioactivation

John D. Bauer, Jeffrey A. Sunman, Michael S. Foster, Jeremy R. Thompson, Alison A. Ogonowski, Stephen J. Cutler, Sheldon W. May and Stanley H. Pollock

Journal of Pharmacology and Experimental Therapeutics November 30, 2006, DOI: https://doi.org/10.1124/jpet.106.110940

Share This Article: